NO831098L - Peptider med spesifiteten til munn- og klovsyke-virus-antigener - Google Patents

Peptider med spesifiteten til munn- og klovsyke-virus-antigener

Info

Publication number: NO831098L
Authority: NO; Norway
Prior art keywords: peptide; fmdv; peptides; amino acid; subtypes
Prior art date: 1982-03-26

Application number

NO831098A

Other languages

English (en)

Norwegian (no)

Inventor

Heinz E Schaller

Eberhard P Pfaff

Original Assignee

Biogen Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-03-26

Filing date

1983-03-25

Publication date

1983-09-27

1983-03-25 Application filed by Biogen Nv filed Critical Biogen Nv

1983-09-27 Publication of NO831098L publication Critical patent/NO831098L/no

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims description 147
102000004196 processed proteins & peptides Human genes 0.000 title claims description 95
239000000427 antigen Substances 0.000 title claims description 22
102000036639 antigens Human genes 0.000 title claims description 22
108091007433 antigens Proteins 0.000 title claims description 22
201000010099 disease Diseases 0.000 title description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 5
244000061408 Eugenia caryophyllata Species 0.000 title 1
235000016639 Syzygium aromaticum Nutrition 0.000 title 1
241000710198 Foot-and-mouth disease virus Species 0.000 claims description 67
101710118046 RNA-directed RNA polymerase Proteins 0.000 claims description 36
241000700605 Viruses Species 0.000 claims description 36
101710132601 Capsid protein Proteins 0.000 claims description 34
101710197658 Capsid protein VP1 Proteins 0.000 claims description 33
101710108545 Viral protein 1 Proteins 0.000 claims description 33
238000000034 method Methods 0.000 claims description 30
239000000203 mixture Substances 0.000 claims description 25
125000003275 alpha amino acid group Chemical group 0.000 claims description 21
150000001413 amino acids Chemical class 0.000 claims description 19
241001465754 Metazoa Species 0.000 claims description 18
230000000890 antigenic effect Effects 0.000 claims description 16
238000004519 manufacturing process Methods 0.000 claims description 12
208000015181 infectious disease Diseases 0.000 claims description 10
241000283973 Oryctolagus cuniculus Species 0.000 claims description 9
238000010790 dilution Methods 0.000 claims description 9
239000012895 dilution Substances 0.000 claims description 9
108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
230000003472 neutralizing effect Effects 0.000 claims description 8
230000008878 coupling Effects 0.000 claims description 5
238000010168 coupling process Methods 0.000 claims description 5
238000005859 coupling reaction Methods 0.000 claims description 5
238000002347 injection Methods 0.000 claims description 4
239000007924 injection Substances 0.000 claims description 4
102100031974 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Human genes 0.000 claims description 2
101000703754 Homo sapiens CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Proteins 0.000 claims description 2
101000641077 Homo sapiens Diamine acetyltransferase 1 Proteins 0.000 claims description 2
101000713305 Homo sapiens Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 claims description 2
238000003556 assay Methods 0.000 claims description 2
230000008569 process Effects 0.000 claims description 2
102100030100 Sulfate anion transporter 1 Human genes 0.000 claims 1
229960005486 vaccine Drugs 0.000 description 29
108090000623 proteins and genes Proteins 0.000 description 24
238000005259 measurement Methods 0.000 description 20
102000004169 proteins and genes Human genes 0.000 description 19
102000014914 Carrier Proteins Human genes 0.000 description 14
108010078791 Carrier Proteins Proteins 0.000 description 14
229920001184 polypeptide Polymers 0.000 description 14
238000003786 synthesis reaction Methods 0.000 description 9
239000008280 blood Substances 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
230000000694 effects Effects 0.000 description 6
241000283690 Bos taurus Species 0.000 description 5
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
229940098773 bovine serum albumin Drugs 0.000 description 5
239000000243 solution Substances 0.000 description 5
208000007212 Foot-and-Mouth Disease Diseases 0.000 description 4
108020004511 Recombinant DNA Proteins 0.000 description 4
JXCHMDATRWUOAP-UHFFFAOYSA-N diisocyanatomethylbenzene Chemical compound O=C=NC(N=C=O)C1=CC=CC=C1 JXCHMDATRWUOAP-UHFFFAOYSA-N 0.000 description 4
239000012634 fragment Substances 0.000 description 4
229940031626 subunit vaccine Drugs 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
230000004807 localization Effects 0.000 description 3
239000002773 nucleotide Substances 0.000 description 3
125000003729 nucleotide group Chemical group 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000700721 Hepatitis B virus Species 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
241000276498 Pollachius virens Species 0.000 description 2
241000282887 Suidae Species 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
208000002672 hepatitis B Diseases 0.000 description 2
230000036039 immunity Effects 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
230000000415 inactivating effect Effects 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
108091005601 modified peptides Proteins 0.000 description 2
125000000896 monocarboxylic acid group Chemical group 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
208000037821 progressive disease Diseases 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
230000004044 response Effects 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
229960004854 viral vaccine Drugs 0.000 description 2
238000005406 washing Methods 0.000 description 2
230000003313 weakening effect Effects 0.000 description 2
VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
-1 3 -dimethylaminopropyl Chemical group 0.000 description 1
108010064733 Angiotensins Proteins 0.000 description 1
102000015427 Angiotensins Human genes 0.000 description 1
101710145634 Antigen 1 Proteins 0.000 description 1
101800004538 Bradykinin Proteins 0.000 description 1
102400000967 Bradykinin Human genes 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
241000252095 Congridae Species 0.000 description 1
108010041986 DNA Vaccines Proteins 0.000 description 1
102100034274 Diamine acetyltransferase 1 Human genes 0.000 description 1
102000016607 Diphtheria Toxin Human genes 0.000 description 1
108010053187 Diphtheria Toxin Proteins 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
101000640813 Homo sapiens Sodium-coupled neutral amino acid transporter 2 Proteins 0.000 description 1
101000716973 Homo sapiens Thialysine N-epsilon-acetyltransferase Proteins 0.000 description 1
102100034349 Integrase Human genes 0.000 description 1
241000726306 Irus Species 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
101710175243 Major antigen Proteins 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
101710085938 Matrix protein Proteins 0.000 description 1
101710127721 Membrane protein Proteins 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000025414 Pentalagus furnessi Species 0.000 description 1
101710176384 Peptide 1 Proteins 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000193996 Streptococcus pyogenes Species 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
108010008038 Synthetic Vaccines Proteins 0.000 description 1
102100020926 Thialysine N-epsilon-acetyltransferase Human genes 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
241000723873 Tobacco mosaic virus Species 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
230000001147 anti-toxic effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
235000021028 berry Nutrition 0.000 description 1
238000009534 blood test Methods 0.000 description 1
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
229910000071 diazene Inorganic materials 0.000 description 1
238000011978 dissolution method Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000003670 easy-to-clean Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
239000011888 foil Substances 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
230000003902 lesion Effects 0.000 description 1
108010000761 leucylarginine Proteins 0.000 description 1
239000000463 material Substances 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000000734 protein sequencing Methods 0.000 description 1
229940023143 protein vaccine Drugs 0.000 description 1
108010006230 protelin Proteins 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
238000004904 shortening Methods 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000012916 structural analysis Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
229940014800 succinic anhydride Drugs 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
210000002268 wool Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/222—Foot and mouth disease related

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO831098A 1982-03-26 1983-03-25 Peptider med spesifiteten til munn- og klovsyke-virus-antigener NO831098L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8209041		1982-03-26

Publications (1)

Publication Number	Publication Date
NO831098L true NO831098L (no)	1983-09-27

Family

ID=10529329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO831098A NO831098L (no)	1982-03-26	1983-03-25	Peptider med spesifiteten til munn- og klovsyke-virus-antigener

Country Status (10)

Country	Link
US (1)	US4605512A (fr)
EP (1)	EP0090581A3 (fr)
JP (1)	JPS58213723A (fr)
AU (1)	AU1255383A (fr)
DK (1)	DK139083A (fr)
ES (1)	ES520997A0 (fr)
IL (1)	IL68201A0 (fr)
NO (1)	NO831098L (fr)
PT (1)	PT76451B (fr)
ZA (1)	ZA831854B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0105346B1 (fr) *	1982-04-14	1991-11-13	BITTLE, James L.	Antigene synthetique du picornavirus
US5230888A (en) *	1982-05-06	1993-07-27	Massachusetts Institute Of Technology	Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
DE3378054D1 (en) *	1982-10-11	1988-10-27	Nat Res Dev	Polypeptides useful in vaccination against enteroviruses
GB8301928D0 (en) *	1983-01-24	1983-02-23	Nicholson B H	Process for producing polypeptides
AU576750B2 (en) *	1983-03-08	1988-09-08	Chiron Mimotopes Pty Ltd	Method of determining antigenically active amino acid sequences
AU573574B2 (en) *	1983-03-08	1988-06-16	Chiron Mimotopes Pty Ltd	Immunogenic deteminants of foot and mouth disease virus
NZ207394A (en) *	1983-03-08	1987-03-06	Commw Serum Lab Commission	Detecting or determining sequence of amino acids
CA1247080A (fr) *	1983-03-08	1988-12-20	Commonwealth Serum Laboratories Commission	Sequences d'acides amines ayant une activite antigenique
WO1984003506A1 (fr) *	1983-03-08	1984-09-13	Commw Serum Lab Commission	Sequences d'acides amines antigeniquement actives
US4894332A (en) *	1985-03-27	1990-01-16	Biogen, Inc.	DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4732971A (en) *	1985-06-03	1988-03-22	Eli Lilly And Company	Synthetic vaccines for foot and mouth disease
US6024964A (en) *	1985-06-24	2000-02-15	Hoechst Aktiengesellschaft	Membrane anchor/active compound conjugate, its preparation and its uses
DE3813821A1 (de) *	1988-04-22	1989-11-02	Hoechst Ag	Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
US6074650A (en) *	1985-06-24	2000-06-13	Hoechst Aktiengesellschaft	Membrane anchor/active compound conjugate, its preparation and its uses
US5827821A (en)	1987-12-10	1998-10-27	The Burnham Institute	Conformationally stabilized cell adhesion peptides
AU639409B2 (en) *	1987-12-10	1993-07-29	La Jolla Cancer Research Foundation	Conformationally stabilized cell adhesion peptides
US5864008A (en) *	1988-03-25	1999-01-26	James; Stephen	Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
JPH03504975A (ja) *	1988-06-14	1991-10-31	セル―エスシーアイ　コーポレイション	異種官能性細胞免疫剤、それを含有するワクチン及びその使用方法
US6521594B1 (en)	1990-04-06	2003-02-18	La Jolla Cancer Research Foundation	Method and composition for treating thrombosis
US5672585A (en) *	1990-04-06	1997-09-30	La Jolla Cancer Research Foundation	Method and composition for treating thrombosis
US5612311A (en) *	1990-04-06	1997-03-18	La Jolla Cancer Research Foundation	Method and composition for treating thrombosis
US5780303A (en) *	1990-04-06	1998-07-14	La Jolla Cancer Research Foundation	Method and composition for treating thrombosis
US5648330A (en) *	1990-04-06	1997-07-15	La Jolla Cancer Research Foundation	Method and composition for treating vascular graft occlusion
DE69126871T2 (de) *	1990-04-06	1998-03-12	Jolla Cancer Res Found	Verfahren und verbindung zur behandlung von thrombose
DE19638044A1 (de) *	1996-09-18	1998-03-19	Bayer Ag	Immunogene Peptide von Maul- und Klauenseuchen-Viren
CN105175516B (zh) *	2009-06-04	2018-11-27	中牧实业股份有限公司	一种动物用肽疫苗及其制备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL62833A (en) *	1980-05-12	1984-12-31	Biogen Nv	Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
FI811009L (fi) *	1980-06-06	1981-12-07	Biogen Nv	Foerbaettrade vektorer foerfaranden foer framstaellning av dessa vektorer och foer expression av klonade gener
IL63224A (en) *	1980-07-17	1985-05-31	Scripps Clinic Res	Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
FR2490239A1 (fr) *	1980-09-18	1982-03-19	Wellcome Found	Molecule d'acide desoxyribonucleique comprenant une sequence de nucleotides correspondant a des proteines du virus de la fievre aphteuse, son procede d'obtention et vaccin obtenu
FI821466A7 (fi) *	1981-04-29	1982-10-30	Biogen Nv	Bacillus-kloonausvektorit, yhdistelmä- DNA-molekyylit, niiden transformoimat Bacillus-isännät sekä menetelmätvieraiden DNA- sekvenssien ekspressiota varten sekä näiden koodaamien polypeptidien tuottamiseksi.
EP0105346B1 (fr) *	1982-04-14	1991-11-13	BITTLE, James L.	Antigene synthetique du picornavirus
EP0105481A1 (fr) *	1982-09-30	1984-04-18	The Wellcome Foundation Limited	Antigènes et vaccins contenant ces antigènes

1983
- 1983-03-16 ZA ZA831854A patent/ZA831854B/xx unknown
- 1983-03-17 AU AU12553/83A patent/AU1255383A/en not_active Abandoned
- 1983-03-22 EP EP83301589A patent/EP0090581A3/fr not_active Withdrawn
- 1983-03-23 IL IL68201A patent/IL68201A0/xx unknown
- 1983-03-24 JP JP58048067A patent/JPS58213723A/ja active Pending
- 1983-03-25 NO NO831098A patent/NO831098L/no unknown
- 1983-03-25 DK DK139083A patent/DK139083A/da not_active Application Discontinuation
- 1983-03-25 ES ES520997A patent/ES520997A0/es active Granted
- 1983-03-25 PT PT76451A patent/PT76451B/pt unknown
- 1983-03-25 US US06/478,901 patent/US4605512A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES8500997A1 (es)	1984-11-01
IL68201A0 (en)	1983-06-15
US4605512A (en)	1986-08-12
ES520997A0 (es)	1984-11-01
EP0090581A2 (fr)	1983-10-05
PT76451B (en)	1986-03-11
DK139083D0 (da)	1983-03-25
AU1255383A (en)	1983-09-29
ZA831854B (en)	1984-01-25
EP0090581A3 (fr)	1984-10-24
JPS58213723A (ja)	1983-12-12
PT76451A (en)	1983-04-01
DK139083A (da)	1983-09-27

Publication	Publication Date	Title
US4605512A (en)	1986-08-12	Small peptides with the specificity of foot and mouth disease viral antigens
US4708871A (en)	1987-11-24	Antigenically active amino acid sequences
NO313917B1 (no)	2002-12-23	Antigen-presenterende kapsid med fusert MS2-kappeprotein
KR20010053042A (ko)	2001-06-25	구제역에 대한 합성 펩티드 백신
WO1999067294A1 (fr)	1999-12-29	Complexe antigenique comprenant un peptide immunostimulateur, cd4 et un domaine de recepteur de chemokine pour traiter vih et des maladies immunitaires
JPH05262667A (ja)	1993-10-12	ウイルス抗原を用いるワクチン
NO166466B (no)	1991-04-15	Fremgangsmaate for detektering eller bestemmelse av et peptid inneholdende en antigenisk aktiv sekvens av aminosyrer.
KR100927221B1 (ko)	2009-11-16	Ｅ형 간염 바이러스의 폴리펩티드 단편, 그를 이용한 백신조성물 및 진단용 키트
EA022788B1 (ru)	2016-03-31	Новые терапевтические и диагностические средства
EP0661999B1 (fr)	1998-12-30	Vaccins destines a lutter contre le virus immunodeficitaire felin
US7604961B2 (en)	2009-10-20	VP1 of foot-and-mouth disease virus
Frangione-Beebe et al.	2000	Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide
CN102180952A (zh)	2011-09-14	口蹄疫病毒抗原多肽、融合抗原多肽及疫苗
CN101257917B (zh)	2016-02-10	针对黄病毒科病毒感染的嵌合多肽及其治疗应用
CA1271717A (fr)	1990-07-17	Polypeptides utiles dans la vaccination contre les enterovirus
RU2181379C2 (ru)	2002-04-20	Пептид (варианты) и способ его производства, фармацевтическое средство, антитело и способ его производства
US4857634A (en)	1989-08-15	Peptides useful in vaccination against enteroviruses
CN107365367A (zh)	2017-11-21	A型口蹄疫病毒vp1蛋白抗原表位基因多肽及其应用
JP2004121266A (ja)	2004-04-22	コンビナトリアルポリペプチド抗原
González et al.	1992	Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain
CN115850398A (zh)	2023-03-28	新型冠状病毒奥密克戎系列变异株的多肽组合物及其应用
Bachrach	1985	Foot-and-mouth disease and its antigens
JP3940676B2 (ja)	2007-07-04	日本脳炎ウイルスに対するキメラｔヘルパー細胞−ｂ細胞ペプチドワクチン
CA1287447C (fr)	1991-08-06	Peptides utiles dans les vaccins contre des enterovirus
CA2143187C (fr)	2007-05-22	Vaccins anti-virus d'immunodeficience chez les felins